Director, CCIA Product Portfolio Strategy & Enablement (REMOTE - USA) -- Minneapolis / St Paul area preferred at Danaher Corporation

Chaska, Minnesota, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Diagnostics, Healthcare, Medical DevicesIndustries

Requirements

20+ years of experience with a Bachelor's degree in biological sciences, engineering, medicine, and/or business management OR 18+ years of experience with a Master's / Doctoral degree in biological sciences, engineering, medicine, and/or business management
Proven track record of success in product innovation and/or lifecycle management within the Diagnostics industry or a related field (e.g., Medical Device, Pharmaceuticals, Biotechnology, Life Sciences)
Deep knowledge of the healthcare industry
Excellent analytical and strategic thinking skills, with a strong track record of driving market insights and translating them into actionable product opportunities
Strong collaborative leadership style, with a strong track record of driving results with cross-functional teams

Responsibilities

Establish Immunoassay portfolio strategy & priorities, managing Beckman’s execution roadmap that drives new product development, product lifecycle management, and global product registration expansion & protection
Partner with product management leadership to provide a clear vision for best-in-class product management capabilities and coach Innovation & Technical Product Managers towards it; build and maintain strong relationships with R&D, Clinical & Regulatory Affairs, Marketing, Operations, and Quality
Own & improve Beckman product management processes for evaluating and prioritizing product innovation opportunities, including business case development, forecasting, portfolio metrics, comparison methodologies, and product strategy review forums
Own & improve Beckman product management processes for collecting excellent voice of customer & other customer insights (incl. quantitative surveys) acting as a subject matter expert and coaching product managers to translate customer needs into compelling product strategies & concepts
Assess, prioritize, and lead cross-portfolio initiatives related to product quality, lifecycle management, regulatory changes, and margin improvement (e.g., assay formulation changes, packaging, IVDR)
Support Beckman’s VP of Immunoassay Innovation, Product, & Program Management in defining and prioritizing Beckman’s Immunoassay innovation and R&D pipeline for future diagnostic solutions
Lead cross-functional initiatives and capability building to support product management across the product lifecycle
Identify unmet clinical needs and translate those needs into groundbreaking products and manage the sustainment and post-launch evolution of the product portfolio

Skills

Product Portfolio Strategy

R&D Pipeline Management

Cross-Functional Leadership

Product Lifecycle Management

Immunoassay Innovation

New Product Development

Clinical Needs Identification

Roadmap Execution

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters

1969Year Founded

IPOCompany Stage

Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries

10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.

Potential regulatory challenges in the EU for water quality sector.

Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.

The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.

Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.

Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.

Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI

Try Jobo Free